Manipulating the Genome of Human Embryos: Some Unforeseen Effects
By Craig Holdrege,
The Nature Institute
| 06. 22. 2015
Untitled Document
In recent years scientists have developed powerful tools to create specific breaks in DNA sequences. They can then either repair those breaks or introduce new DNA into the sequence at the site of the break. These are called genome editing techniques. Two main techniques at present are the CRISPR-Cas9 system and zinc-finger nucleases. In principle, researchers can modify any part of the genome. They have achieved intended modifications in experiments with human and animal cells and also with mouse embryos. But the specific alterations do not always occur and there are also unintended effects.
The techniques are not as precise as they are sometimes made out to be, so there is every reason for caution in their application, especially in connection with the manipulation of human cells or human embryos. But over and beyond technical issues is the pressing ethical concern: should researchers cross the line into genetically manipulating human embryos?
Knowing that scientists in China were performing these experiments, two groups of researchers and others published comments in Science and Nature in March 2015 warning about...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...